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Abstract: This study screened the available evidence for the in vitro antimicrobial efficacy 
of propolis, a natural herbal resin bee product, against a selection of three bacterial species 
of relevance to oral diseases. For this purpose, papers dealing with laboratory studies 
assessing minimum inhibitory concentration (MIC), minimum bactericidal concentrations 
(MBC) or the agar diffusion method to analyze the antimicrobial properties of propolis on 
three oral pathogens (S. mutans, P. gingivalis, F. nucleatum) and a yeast (C. albicans) are 
reviewed. Overall, a positive antimicrobial effect could be shown. However, when 
compared to the commonly used control substances (e.g., specific antibiotics, antiseptics 
and antifungals), propolis appeared less effective, depending on the bacterial strain, and 
required higher concentrations than the control substances, in order to show a measurable 
effect. Nevertheless, propolis as a natural herbal resin bee product can be considered as a 
natural antiseptic agent within the range of other herbal products, like sanguinarine. 
Therefore, it may be a valuable compound of non-synthetic, natural origin for patients 
seeking complementary agents and alternatives for “hard” chemicals. 
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1. Introduction 
Bacteria are recognized to be a main causative factor for the development of periodontitis and 
caries. It has been shown that professional plaque control will thus prevent disease initiation and stop 
its progression. Thus, the main treatment target remains the effective reduction of the supra- and sub-
gingival pathogenic flora, mostly by mechanical means. However, a variety of chemical means, like 
antibiotics and antiseptics, have been introduced as an adjunct to mechanical therapy [1,2]. Whereas  
the use of antibiotics is warranted in certain cases, especially in aggressive cases or patients with AN 
insufficient response to non-surgical therapy, it is associated with certain risks, notably the development 
of antibiotic resistance in various bacterial species [3]. The administration of antimicrobial agents as  
a quick and inexpensive means of supporting mechanical periodontal debridement is therefore still 
worth consideration [4]. Alongside well-investigated and established chemicals frequently used in 
gingivitis/periodontitis prophylaxis and treatment protocols, like chlorhexidine or iodine, natural 
products may represent a suitable alternative, exhibiting less or no side effects [5]. Among them, 
herbal bee products, like honey and propolis, have a great potential to be used as adjuncts to 
mechanical periodontal treatment and infection control, as well. 
Propolis is a honeybee product, which is used to cover hive walls and fill gaps. Bees collect  
the resin-like product from cracks in the bark of trees and leaf buds [6,7]. Thereby, propolis does not 
only act as a structural compound, but is mainly responsible as a chemical agent for the safety of 
honeycombs, especially against microorganisms [8–10]. The chemical composition of propolis is highly 
variable and depends on the local flora at the site of collection and on the season of collection [11–13]. 
It is a lipophilic, resinous material collected from living plants, which is mixed with the enzyme,  
beta-glycosidase, present in the bees’ saliva, partially digested and added to beeswax to form the final 
product [14]. Despite potential intrinsic differences, which may depend on the origin, it has been 
proven that most propolis variants have a wide range of biological therapeutic effects, such as 
antimicrobial, antifungal and antiviral activity [10,15,16]. Therefore, sufficient evidence is available in 
the literature to justify propolis as a good candidate adjunct to prevent or treat infectious diseases. 
Several laboratory studies exist, which assessed the antimicrobial potential of propolis using different  
in vitro test systems in order to evaluate the potential to inhibit the bacterial growth (bacteriostasis) or 
to induce bacterial death (bactericidal effect). To measure this potential, several evaluation methods 
are available, e.g., simple agar diffusion tests or dissolution assays. The latter determine either the 
minimum inhibitory (MIC), the minimum bactericidal concentrations (MBC) or agar diffusion tests, 
which, in principle, visually or optically assess the inhibition of bacterial growth. These tests are 
therefore commonly used to determine the potential of the agents and to classify them in relation to 
alternative chemical substances (controls). Antimicrobials are usually regarded as bactericidal, if the 
MBC is not more than four times the MIC [17]. Based on microbiological data derived from such 
assays, it has been suggested that propolis may even be of clinical value [18,19]. However, a systematic 
evaluation on the antimicrobial effects of propolis on bacterial species relevant to oral diseases and 
dentistry in general is still lacking. 
This review therefore aimed to evaluate the evidence for the laboratory efficacy of propolis against  
a selection of three bacterial species with a high association with periodontitis and caries (S. mutans,  
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P. gingivalis, F. nucleatum) and a yeast (C. albicans). For this purpose, articles published in between 
1960 and 2013 were screened. 
2. Materials and Methods 
2.1. Search Strategy 
In order to conduct a review of the data published on the specific subject of interest, a literature 
search of the U.S. National Library of Medicine (PubMed) was performed. Articles from the inception 
of these databases up to and including June, 2013, were considered. The following strategy was 
qpplied: ("anti-bacterial agents"[MeSH Terms] OR ("anti-bacterial"[All Fields] AND "agents"[All 
Fields]) OR "anti-bacterial agents"[All Fields] OR "antibacterial"[All Fields] OR "anti-bacterial 
agents"[Pharmacological Action]) OR ("anti-infective agents"[MeSH Terms] OR ("anti-infective"[All 
Fields] AND "agents"[All Fields]) OR "anti-infective agents"[All Fields] OR "antimicrobial"[All 
Fields] OR "anti-infective agents"[Pharmacological Action]) OR ("anti-infective agents"[MeSH 
Terms] OR ("anti-infective"[All Fields] AND "agents"[All Fields]) OR "anti-infective agents"[All 
Fields] OR "antiinfective"[All Fields] OR "anti-infective agents"[Pharmacological Action]) OR 
("disinfection"[MeSH Terms] OR "disinfection"[All Fields]) OR bactericidal[All Fields] OR 
bacteriostatic[All Fields] AND ("propolis"[MeSH Terms] OR "propolis"[All Fields]). 
2.2. Study Selection 
In the first step, two reviewers (the first and second author) independently screened all titles and  
then the abstracts of the electronic search and assessed them for possible inclusion in the review. All 
potentially eligible studies were ordered, and their full texts were assessed. Only studies written in 
English, German, French and Italian were included. Studies reporting on animal, gynecological, 
laryngological and dermatological experiments were excluded. Any disagreement concerning inclusion 
was resolved by discussion. 
2.3. Eligibility Criteria for Studies 
After reading the full text of the selected studies, the assessed bacterial taxa assessed and  
the methodologies used were recorded and the data were resumed in tables. Only studies were included 
that used the MIC, MBC or the agar diffusion assays and that investigated the effect of propolis on  
S. mutans, P. gingivalis, F. nucleatum or C. albicans. 
3. Results 
3.1. Search Results 
From the 1,373 titles initially obtained from the literature search, 171 full texts were assessed. Eighty-
six articles were excluded because they were considering animal or dermatological studies. In the next 
step, 57 articles were excluded mainly for the following reasons: 
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- The requested laboratory method was not assessed (i.e., no MIC/MBC or agar diffusion 
evaluation); 
- None of the requested bacteria were assessed. 
Finally, 28 original articles were analyzed that matched the inclusion criteria with regards to  
the three microbiological evaluation methods (Tables 1–4). From each study, the respective results 
were identified and recorded, accordingly. The mean values and ranges (minimum and maximum 
values) were provided, where applicable. 
3.2. Agar Diffusion Method 
Table 1 provides a summarized data set regarding the agar diffusion method. In general, the use of 
propolis resulted in smaller inhibition zones than the respective control media. No available data were 
found for F. nucleatum. In the case of S. mutans, the mean values of the inhibition zones were about 
60% smaller than those of the control groups. The substances commonly used as controls in these 
studies were chlorhexidine and sanguinarine. The inhibition zone for propolis ranged from 0.2 to 22 mm, 
whereas for the control groups, these zones ranged from 25 to 28 mm. For C. albicans, the mean value 
for the zone of inhibition accounted for about 50% of the control groups. The control substances 
commonly used were chlorhexidine, itraconazole and ketoconazole. The inhibition zone for propolis 
ranged from 0.8 to 14 mm, whereas the inhibition for the control groups ranged from 16 to 20 mm. 
3.3. MBC and MIC 
The results of the MBC evaluation indicated that propolis generally did not act as effectively as  
the compared control substances (Table 2). For S. mutans, the required mean MBC was almost  
100-times higher than that of the control group. The control substance in this case was chlorhexidine, 
vestitol and neovestitol. The range of the MBC of propolis was very wide, spanning from 6.25 μg/mL 
to more than 1,600 μg/mL. One study showed that propolis exhibited an antimicrobial effect on  
C. albicans, which was even greater than the control substance, chlorhexidine [21]. 
In Table 3, the result of studies assessing the MIC is provided. Once again, it could be shown that 
the effect of propolis was lower than the control substances, especially when S. mutans and P. gingivalis 
were tested. The MIC for S. mutans was comparable to the ones obtained by the corresponding control 
groups. The mean values of the MIC of propolis ranged from 0.5 to 12,500 μg/mL, whereas those of 
the control groups ranged from 0.015 to 37,500 μg/mL, respectively. For F. nucleatum and C. albicans, 
the mean values of the MIC were only approximately twice as high as the MICs of the control groups. 
For P. gingivalis, however, the MIC of propolis was about 360=times higher than the MIC  
of the control groups. 
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Table 1. Results of the agar diffusion tests (inhibition zones in mm) to evaluate propolis and control compounds (indicated with different 
superscript letters). 
Ref. 
S. mutans P. gingivalis F. nucleatum C. albicans 
Propolis Control Propolis Control Propolis Control Propolis Control 
Min Mean Max  Min Mean Max Min Mean Max  Min Mean Max Min Mean Max  Min Mean Max Min Mean Max  Min Mean Max 
[34] 10 12 13                   9 11 13     
[35]  20  a  28                 14  b  20  
[36] 5.5 5.9 6.3                          
[25]  2       3.4              0.8      
[37]  22  c  27.6                 10.4  c  19  
[38]  13  c  25                 10  c  16  
[39]  15  a  28                 13  b  20  
[40]                       14  d  16  
[41] 0.2 0.3 0.4                          
[42]        18 21.5 25                   
Mean  11.3    27.1   12.45              10.5    18.2  
(a) Sanguinarine; (b) itraconazole; (c) chlorhexidine; (d) ketoconazole; (e) CaOH2; (f) camphorated paramonochlorophenol; (g) formocresol; (h) fluconazol;  
(i) meropenem; (j) penicillin G; (k) penicillin; (l) miconazole; (m) tetracycline; (n) metronidazole; (o) erythromycin; (p) clindamycin. 
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Table 2. MBC (minimal bactericidal concentration; µg/mL) of propolis and control compounds (indicated with different superscript letters). 
Ref. 
S. mutans P. gingivalis F. nucleatum C. albicans 
Propolis Control Propolis Control Propolis Control Propolis Control 
Min Mean Max  Min Mean Max Min Mean Max  Min Mean Max Min Mean Max  Min Mean Max Min Mean Max  Min Mean Max 
[9] 6.25  12.5                          
[21]                       75  c  512  
[43]         384       358.4             
[36]  >1,600                           
[44]  500    8                       
[26]  400                           
[45]                1562.5  e  1,562.5         
                  f  680.0         
                  g  1,480.0         
[46] 200 300 400                          
[47] 53  106                          
[48] 100 150 200                          
                             
[49]  >1,600                           
Mean  758    8   384       960.4    1,240.8   75    512  
(a) Sanguinarine; (b) itraconazole; (c) chlorhexidine; (d) ketoconazole; (e) caoh2; (f) camphorated paramonochlorophenol; (g) formocresol; (h) fluconazol;  
(i) meropenem; (j) penicillin g; (k) penicillin; (l) miconazole; (m) tetracycline; (n) metronidazole; (o) erythromycin; (p) clindamycin. 
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Table 3. MIC (minimal inhibitory concentration; µg/mL) of propolis and control compounds (indicated with different superscript letters). 
Ref. 
S. mutans P. gingivalis F. nucleatum C. albicans 
Propolis Control Propolis Control Propolis Control Propolis Control 
Min Mean Max  Min Mean Max Min Mean Max  Min Mean Max Min Mean Max  Min Mean Max Min Mean Max  Min Mean Max 
[21]                       150  c  512  
[50]  35                           
[51] 8 20 32  0.5 2.025 4                      
[35]  170  a  15                 940  h  10  
[43]         294.4       256             
                             
[36]  100                           
[44]  125  c 1 1.5 2                      
[20]         256  i  1   1024  i  0.06         
           j  0.03     j  4         
[26]  50                           
[45]                390.6  e  781.2         
                  f  170.0         
                  g  371.0         
[46] 50 75 100                          
[38]  200  k  0.0922                 90  l  5.9  
[52] 8 36 64                          
[39]  0.5  a  0.015                4 18 32     
[19]    m  4                 0.8  h  0.01  
    j  0.03                       
    n  4                       
    o  0.5                       
    i  1                       
    p  0.5                       
[47] 3.3 4.95 6.6                          
[48] 100 150 200                          
                             
[53] 
3,13
0 
7,815 12,500                          
[54]                       0.5      
[55]  27,470  n  37500                       
[49] 25 37.5 50                          
[42]        0.01 0.056 0.1                   
Mean  2,419.3    12,500.5   183.5    0.51   556.87    265.3   199.8    132  
(a) Sanguinarine; (b) itraconazole; (c) chlorhexidine; (d) ketoconazole; (e) caoh2; (f) camphorated paramonochlorophenol; (g) formocresol; (h) fluconazol; (i) meropenem; 
(j) penicillin g; (k) penicillin; (l) miconazole; (m) tetracycline; (n) metronidazole; (o) erythromycin; (p) clindamycin. 
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In summary, propolis showed a positive antimicrobial effect. However, when compared to a 
diversity of standard control substances, like established antibiotics, antiseptics and antifungals, 
propolis was less effective and required higher concentrations than the control compounds. 
4. Discussion 
Most oral diseases are primarily caused, or at least modified, by bacteria that inhabit the oral cavity. 
Among them, caries and periodontitis represent the most common pathological conditions, which are 
caused by the biofilm-forming bacteria and yeasts of dental plaque. Accordingly, most of the 
prophylactic and therapeutic interventions aim to reduce the bacterial load in such a way that oral 
health can be maintained or obtained. Antimicrobials are useful to support these efforts by effectively 
inhibiting the formation or removing established biofilms. 
Propolis has been used since ancient times as a remedy for the treatment of many diseases in folk 
medicine. It is considered to be safe in low doses besides its antimicrobial activity [22]. Numerous  
in vitro studies are available on the antimicrobial capacity of propolis, and therefore, the aim of this 
review was to gain an overview of these findings, in order to determine if propolis can be considered 
for further clinical investigations of these. For maintaining a focused question, three microbiological 
methods were considered, in investigating four oral species, which included the cariogenic S. mutans, 
the periodontitis-associated P. gingivalis and F. nucleatum (which can be found in several 
inflammatory conditions) and the yeast, C. albicans, which is involved in oral candidiasis. In this 
context, it should also be clarified that neither definitive conclusions about a wider range of pathogens, 
nor the efficacy of propolis on clinically applicable models can be made from this review. In 
particular, a starting point for the latter would be the study of the effect of propolis on more complex 
biofilm models. A. naeslundii would also have been potentially interesting. However only two studies 
included this bacteria, and therefore, these studies could not be considered in this review. In this 
context, other potential relevant databases, such as The Biological Abstracts, Chemical Abstracts, 
Medline, Web of Science, Highwire and Lilacs, could have been helpful. However, since we were 
focusing more on dental and medical applications and related bacteriology, our search was limited to 
PubMed. Its use resulted already in a large number of potential literature. 
By the single bacterial approach and the narrowed microbiological assays targeted by the present 
review, the collected data allowed for a ground comparison of the effectiveness of propolis, in 
comparison to some standard antimicrobial agents, which are designated in this paper as “controls”. 
However, the heterogeneity of the controls ranging from frequently-used antiseptics, like chlorhexidine, 
to antibiotics still made a direct comparison difficult. Nevertheless, as a principal finding, it could be 
elaborated that propolis showed a clear antibacterial effect, which was, however, less effective than the 
investigated control agents and required, in fact, higher concentrations than those (10- to 100-times 
higher MIC and MBC). The inhibition zones in the agar diffusion test were correspondingly smaller in 
comparison to the control substances. However, these overall differences could hypothetically be 
narrower in real-life application, given the fact that the total concentrations of various medicaments 
must anyway be even greater under clinical conditions than in the planktonic state, in order to obtain a 
successful microbiological outcome [23]. 
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Another matter to consider when comparing these studies is, on the one hand, the large number of 
control substances used and, on the other hand, the different origin and formulation of propolis. Most 
of these studies that have assessed propolis come from Brazil (Table 4). Propolis from this origin 
showed superior effectiveness, compared to others [24–26]. Clearly, the composition of propolis 
depends upon the vegetation of the area from which it is collected [27]. This natural or intrinsic 
potential is also influenced by the galenic formulation and preparation, e.g., the use of solvents, like 
alcohol. Therefore, it is difficult to assess and rate the sole activity of propolis itself in this context. 
Table 4. Geographic origin of propolis. 
Number of Publications Origin of Propolis 
14 Brazil 
2 Greece 
2 Turkey 
2 Laboratory-manufactured 
1 Korea 
1 Tunisia  
1 Argentina and Uruguay 
1 Uruguay 
1 Czech Republic 
1 European-Siberian 
1 Irano-Turanian 
1 Lithuania 
1 Poland 
1 China 
In the obtained literature, sanguinarine is described as another natural product showing an 
antibacterial effect, exhibiting an effective plaque-inhibiting potential. It is isolated from Sanguinaria 
canadensis and has been widely used in industrial toothpaste and mouthwash products [28]. The MIC 
and MBC for sanguinarine against S. mutans, as an example, were reported to be 15.6 and 31.3 µg/mL, 
respectively, which was also much higher than the respective values obtained for chlorhexidine, which 
accounted for 1 and 2 µg/mL. Unfortunately, no data regarding the MIC of chlorhexidine was 
available as a control agent with regard to periodontal bacteria [29]. Stanley and co-workers 
systematically determined the susceptibility to chlorhexidine of a range of bacteria isolated from 
subgingival plaque. The modal value of the MIC was found to be 62 µg/mL, and 64% of the strains 
tested were inhibited at this concentration. A concentration of 250 µg/mL of chlorhexidine inhibited 
the growth of all bacteria in the 25 subgingival plaque samples investigated [30]. 
Propolis therefore also displayed an antibacterial potential, although weaker than other conventional 
pharmaceutical substances testes. However, despite the fact that the antibacterial efficacy of propolis 
may be somewhat limited, the ongoing search and evaluation of natural products is still warranted [31]. 
Interestingly, besides its antimicrobial potential, propolis has also been shown to inhibit the adherence 
of S. mutans onto glass, which offers a “preventive” advantage, for instance in terms of biofilm formation 
and establishment [32]. In one instance, propolis showed antimicrobial activity similar to 
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chlorhexidine and even greater than clove or sage extracts in a study using bacteria from the saliva of 
periodontally healthy subjects and those with chronic periodontitis [33]. 
5. Conclusions 
Therefore, propolis has the potential, especially in the case of S. mutans, to develop into an 
antiseptic agent, but higher concentrations may be required. The product offers an alternative for 
patients seeking complementary agents and alternatives from synthetic chemicals. Especially for  
long-term usage, it may also be a valuable option, but the possibility of allergic or other adverse 
reactions should not be neglected and should be investigated further. 
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